Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Language
  • +91 11 4925 6000
  • Request information
  • +91 11 4925 6000
  • Part of brands: |
IndiaIndia
  • Part of brands: |
  • We guide you
    • Fertility
    • Inherited diseases
    • Worry-free pregnancy
  • Reproductive Health
    • Specialists
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS+ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • ALICE
      • Endometrio
      • Family POC
    • Patients
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS + ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • Family POC
      • ALICE
      • Endometrio
  • Diagnostic
  • About us
    • Igenomix Research
    • About Igenomix
  • ACADEMY
Genomics Precision Diagnostic > Neurology Precision Panel > Epileptic Encephalopathy and Early Infantile Epileptic Encephalopathy Precision Panel

Epileptic Encephalopathy and Early Infantile Epileptic Encephalopathy Precision Panel

Epileptic Encephalopathy and Early Infantile Epileptic Encephalopathy (EIEE) describes a clinical and genetic heterogeneous group of epilepsy syndromes associated with severe cognitive and behavioral abnormalities. 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Epileptic Encephalopathy and Early Infantile Epileptic Encephalopathy (EIEE) describes a clinical and genetic heterogeneous group of epilepsy syndromes associated with severe cognitive and behavioral abnormalities. Clinically these disorders vary in their age of onset, developmental outcome, etiologies, neuropsychological deficits, seizure types and prognosis. The difference between these two entities relies in the age of onset, EIEE manifests in the first year of life. Identifiable factors that may influence the course and degree of cognitive and behavioral impairment in these disorders include underlying etiology, age of onset, seizure frequency and severity, cumulative detrimental effect and genetic factors. Genetically these disorders can be caused by de novo mutations, but they can also be inherited in an autosomal dominant, recessive or X-linked pattern.  
  • The Igenomix Epileptic Encephalopathy and Early Infantile Epileptic Encephalopathy (EIEE) Precision Panel  can serve as an accurate and directed diagnostic tool as well as for a differential diagnosis for early onset epilepsy ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.

Indication

  • The Igenomix Epileptic Encephalopathy and Early Infantile Epileptic Encephalopathy (EIEE) Precision Panel is indicated in patients with a clinical suspicion or diagnosis presenting with the following manifestations: 
    • Early-onset seizures 
    • Metabolic abnormalities 
    • Myoclonic and partial motor seizures 
    • Infantile spasms 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular diagnosis for an accurate clinical diagnosis of a symptomatic patient.    
  • Early initiation of treatment with a multidisciplinary team in the form of medical care with antiepileptic drugs, corticosteroids, vigilance and monitorization of cognitive status as well as surgical care if needed.  
  • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
  • Improvement of delineation of genotype-phenotype correlation.  

Genes & Diseases

Methodology

References

See scientific referrals

Olson, H. E., Kelly, M., LaCoursiere, C. M., Pinsky, R., Tambunan, D., Shain, C., Ramgopal, S., Takeoka, M., Libenson, M. H., Julich, K., Loddenkemper, T., Marsh, E. D., Segal, D., Koh, S., Salman, M. S., Paciorkowski, A. R., Yang, E., Bergin, A. M., Sheidley, B. R., & Poduri, A. (2017). Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression. Annals of neurology, 81(3), 419–429. https://doi.org/10.1002/ana.24883 

Aeby, A., Sculier, C., Bouza, A. A., Askar, B., Lederer, D., Schoonjans, A. S., Vander Ghinst, M., Ceulemans, B., Offord, J., Lopez-Santiago, L. F., & Isom, L. L. (2019). SCN1B-linked early infantile developmental and epileptic encephalopathy. Annals of clinical and translational neurology, 6(12), 2354–2367. https://doi.org/10.1002/acn3.50921 

Nashabat, M., Al Qahtani, X. S., Almakdob, S., Altwaijri, W., Ba-Armah, D. M., Hundallah, K., Al Hashem, A., Al Tala, S., Maddirevula, S., Alkuraya, F. S., Tabarki, B., & Alfadhel, M. (2019). The landscape of early infantile epileptic encephalopathy in a consanguineous population. Seizure, 69, 154–172. https://doi.org/10.1016/j.seizure.2019.04.018 

Khan, S., & Al Baradie, R. (2012). Epileptic Encephalopathies: An Overview. Epilepsy Research And Treatment, 2012, 1-8. doi: 10.1155/2012/403592 

Kural, Z., & Ozer, A. (2012). Epileptic Encephalopathies in Adults and Childhood. Epilepsy Research And Treatment, 2012, 1-8. doi: 10.1155/2012/205131 

Radaelli, G., de Souza Santos, F., Borelli, W. V., Pisani, L., Nunes, M. L., Scorza, F. A., & da Costa, J. C. (2018). Causes of mortality in early infantile epileptic encephalopathy: A systematic review. Epilepsy & behavior : E&B, 85, 32–36. https://doi.org/10.1016/j.yebeh.2018.05.015 

Spagnoli, C., Frattini, D., Rizzi, S., Salerno, G. G., & Fusco, C. (2019). Early infantile SCN1A epileptic encephalopathy: Expanding the genotype-phenotype correlations. Seizure, 65, 62–64. https://doi.org/10.1016/j.seizure.2019.01.002 

descargar

Detail description

Download



IGENOMIX_PartOfVitrolifeGroup_black

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

OUR SERVICES

Genetic solutions
Learn about genetics
How to send a sample

ABOUT US

About Igenomix
Contact
Quality
Work with us

FOLLOW IGENOMIX

Blog: Path to fertility

  +91 11 4925 6000
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Language

[2024] © Igenomix Privacy policy Quality policy Legal note Cookies policy




  • We guide you
    • Fertility
    • Inherited diseases
    • Worry-free pregnancy
  • Reproductive Health
    • Specialists
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS+ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • ALICE
      • Endometrio
      • Family POC
    • Patients
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS + ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • Family POC
      • ALICE
      • Endometrio
  • Diagnostic
  • About us
    • Igenomix Research
    • About Igenomix
  • ACADEMY
  • Language
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT